A phase 1b dose-escalation trial of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer (MCRC) patients.

被引：0
|
作者：
Delord, JP
Beale, P
Van Cutsem, E
Clarke, S
Verslype, C
Bugat, R
Rakhit, A
Fettner, S
Brennscheidt, U
Feyereislova, A
机构：
[1] Inst Claudius Regaud, Toulouse, France
[2] Sydney Canc Ctr, Sydney, NSW, Australia
[3] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
[4] F Hoffmann La Roche & Co Ltd, Nutley, NJ USA
[5] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
[6] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3585
引用
收藏
页码：266S / 266S
页数：1
相关论文
共 50 条
  • [1] A phase Ib dose-escalation study of erlotinib, capecitabine and oxaliplatin in metastatic colorectal cancer patients
    Van Cutsem, E.
    Verslype, C.
    Beale, P.
    Clarke, S.
    Bugat, R.
    Rakhit, A.
    Fettner, S. H.
    Brennscheidt, U.
    Feyereislova, A.
    Feyereislova, A.
    Delord, J. -P.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (02) : 332 - 339
  • [2] Phase II study of capecitabine, oxaliplatin and erlotinib in previously treated patients with metastatic colorectal cancer (MCRC).
    Meyerhardt, JA
    Xhu, A
    Enzinger, PC
    Ryan, DP
    Clark, JW
    Kulke, MH
    Michelini, A
    Vincitore, M
    Thomas, A
    Fuchs, CS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 265S - 265S
  • [3] Erlotinib in combination with capecitabine and docetaxel in patients with metastatic breast cancer: A dose-escalation study
    Twelves, Chris
    Trigo, Jose M.
    Jones, Rob
    De Rosa, Flavio
    Rakhit, Ashok
    Fettner, Scott
    Wright, Tonya
    Baselga, Jose
    [J]. EUROPEAN JOURNAL OF CANCER, 2008, 44 (03) : 419 - 426
  • [4] Phase I dose-escalation of trifluridine/tipiracil in combination with oxaliplatin in patients with metastatic colorectal cancer
    Argiles, Guillem
    Andre, Thierry
    Hollebecque, Antoine
    Calvo, Aitana
    Dahan, Laetitia
    Cervantes, Andres
    Leger, Catherine
    Amellal, Nadia
    Fougeray, Ronan
    Tabernero, Josep
    [J]. EUROPEAN JOURNAL OF CANCER, 2019, 112 : 12 - 19
  • [5] Tarceva™ (erlotinib) in combination with xeloda and oxaliplatin in patients with metastatic colorectal cancer (CRC) -: A phase I dose escalation trial.
    Van Cutsem, E
    Beale, P
    Delord, JP
    Verslype, C
    Brennscheidt, U
    Feyereislova, A
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6095S - 6096S
  • [6] A dose-escalation study of oxaliplatin/capecitabine/irinotecan (XELOXIRI) and bevacizumab as a first-line therapy for patients with metastatic colorectal cancer
    Sato, Yasushi
    Ohnuma, Hiroyuki
    Hirakawa, Masahiro
    Takahashi, Minoru
    Osuga, Takahiro
    Okagawa, Yutaka
    Murase, Kazuyuki
    Takada, Kohichi
    Kawano, Yutaka
    Iyama, Satoshi
    Hayashi, Tsuyoshi
    Sato, Tsutomu
    Miyanishi, Koji
    Takimoto, Rishu
    Kobune, Masayoshi
    Okita, Kenji
    Mizuguchi, Toru
    Furuhata, Tomohisa
    Hirata, Koichi
    Kato, Junji
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) : 587 - 594
  • [7] A dose-escalation study of oxaliplatin/capecitabine/irinotecan (XELOXIRI) and bevacizumab as a first-line therapy for patients with metastatic colorectal cancer
    Yasushi Sato
    Hiroyuki Ohnuma
    Masahiro Hirakawa
    Minoru Takahashi
    Takahiro Osuga
    Yutaka Okagawa
    Kazuyuki Murase
    Kohichi Takada
    Yutaka Kawano
    Satoshi Iyama
    Tsuyoshi Hayashi
    Tsutomu Sato
    Koji Miyanishi
    Rishu Takimoto
    Masayoshi Kobune
    Kenji Okita
    Toru Mizuguchi
    Tomohisa Furuhata
    Koichi Hirata
    Junji Kato
    [J]. Cancer Chemotherapy and Pharmacology, 2015, 75 : 587 - 594
  • [8] A dose finding study with erlotinib in combination to irinotecan and capecitabine (XELIRI) in metastatic colorectal cancer patients (MCRC)
    Ferrario, E.
    Di Bartolomeo, M.
    Bajetta, E.
    Buzzoni, R.
    Mariani, L.
    Gevorgyan, A.
    Dotti, K.
    Platania, M.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI40 - XI40
  • [9] A phase I dose-escalation of trifluridine/tipiracil in combination with oxaliplatin in metastatic colorectal cancer.
    Hollebecque, Antoine
    Argiles, Guillem
    Andre, Thierry
    Cervantes, Andres
    Leger, Catherine
    Valette, Aude
    Amellal, Nadia
    Fougeray, Ronan
    Tabernero, Josep
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] A Phase 1b Dose-Escalation Study of Carotuximab in Combination with Nivolumab in Patients with Metastatic NSCLC
    Robert, F.
    Gray, J. E.
    Trigeiro, A.
    Adams, B.
    Theuer, C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S725 - S726
12345